|
Elevation Oncology, Inc. (EleD) DCF -Bewertung
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Elevation Oncology, Inc. (ELEV) Bundle
Gewinnen Sie mit unserem ausgefeilten DCF -Taschenrechner Einblick in Ihre Elevation Oncology, Inc. (ELED) -Wundierungsanalyse! Diese Excel -Vorlage wird mit realen (EleD-) Daten vorinstalliert, sodass Sie die Vorhersagen und Annahmen für eine genaue Berechnung des intrinsischen Werts der Elevation Oncology anpassen können.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | -5.9 | -17.3 | -32.0 | -94.5 | -41.5 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Depreciation | 3.6 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| EBIT | -9.5 | -17.3 | -32.0 | -94.5 | -41.5 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Total Cash | 1.7 | 79.4 | 146.3 | 90.3 | 83.1 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Accounts Payable | .5 | 5.7 | 5.6 | 6.4 | .5 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | .0 | -.1 | .0 | -.1 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 |
| Tax Rate, % | -0.06568288 | -0.06568288 | -0.06568288 | -0.06568288 | -0.06568288 | -0.06568288 | -0.06568288 | -0.06568288 | -0.06568288 | -0.06568288 |
| EBITAT | -9.5 | -17.3 | -32.0 | -94.6 | -41.5 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -5.4 | -12.1 | -32.1 | -93.9 | -47.3 | -.5 | .0 | .0 | .0 | .0 |
| WACC, % | 12.51 | 12.51 | 12.51 | 12.51 | 12.51 | 12.51 | 12.51 | 12.51 | 12.51 | 12.51 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -.5 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | 0 | |||||||||
| Net Debt | -19 | |||||||||
| Equity Value | 19 | |||||||||
| Diluted Shares Outstanding, MM | 34 | |||||||||
| Equity Value Per Share | 0.55 |
What You Will Receive
- Pre-Filled Financial Model: Elevation Oncology’s actual data enables accurate DCF valuation.
- Comprehensive Forecast Control: Modify revenue growth, margins, WACC, and other essential drivers.
- Real-Time Calculations: Instant updates ensure you see outcomes as you implement changes.
- Investor-Ready Template: A polished Excel file crafted for high-quality valuation.
- Customizable and Reusable: Designed for adaptability, allowing repeated use for in-depth forecasts.
Key Features
- Comprehensive Financial Data: Gain access to precise pre-loaded historical data and future forecasts for Elevation Oncology, Inc. (ELEV).
- Adjustable Forecast Parameters: Modify highlighted cells for key metrics like WACC, growth rates, and profit margins.
- Real-Time Calculations: Instant updates to DCF, Net Present Value (NPV), and cash flow assessments.
- Interactive Dashboard: User-friendly charts and summaries to easily interpret your valuation outcomes.
- Suitable for All Skill Levels: A straightforward, intuitive design tailored for investors, CFOs, and consultants alike.
How It Works
- Download the Template: Gain immediate access to the Excel-based ELEV DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and more.
- Instant Calculations: The model automatically recalculates Elevation Oncology’s intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential valuation shifts.
- Analyze and Decide: Utilize the findings to inform your investment or financial analysis.
Why Choose This Calculator?
- Accuracy: Leverages real Elevation Oncology financials for precise data.
- Flexibility: Tailored for users to easily test and adjust inputs as needed.
- Time-Saving: Avoid the complexities of creating a DCF model from the ground up.
- Professional-Grade: Crafted with the precision and usability expected at the CFO level.
- User-Friendly: Intuitive design makes it accessible for users without advanced financial modeling skills.
Who Should Use This Product?
- Investors: Accurately assess Elevation Oncology's fair value before making investment decisions.
- CFOs: Utilize a professional-grade DCF model for financial reporting and analysis.
- Consultants: Easily customize the template for valuation reports tailored to clients.
- Entrepreneurs: Understand financial modeling techniques applied by leading biotech firms.
- Educators: Employ it as a teaching resource to illustrate valuation methodologies.
What the Template Contains
- Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for Elevation Oncology, Inc. (ELEV).
- Real-World Data: Elevation Oncology’s historical and projected financials preloaded for analysis.
- Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to test various scenarios specific to Elevation Oncology, Inc. (ELEV).
- Financial Statements: Full annual and quarterly breakdowns for deeper insights into Elevation Oncology's performance.
- Key Ratios: Built-in analysis for profitability, efficiency, and leverage relevant to Elevation Oncology, Inc. (ELEV).
- Dashboard with Visual Outputs: Charts and tables for clear, actionable results regarding Elevation Oncology, Inc. (ELEV).
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.